n-3 Fatty Acids and Human Platelets

Keyword(s):  
1993 ◽  
Vol 13 (10) ◽  
pp. 1105-1111 ◽  
Author(s):  
J.M. Chardigny ◽  
J.L. Sébédio ◽  
P. Juanéda ◽  
J.M. Vatèle ◽  
A. Grandgirard

Platelets ◽  
1995 ◽  
Vol 6 (5) ◽  
pp. 259-264 ◽  
Author(s):  
A. M. Bakken ◽  
T. Hervig ◽  
T. Thorsen ◽  
H. Holmsen
Keyword(s):  

1987 ◽  
Vol 65 (4) ◽  
pp. 405-408 ◽  
Author(s):  
B. J. Weaver ◽  
B.J. Holub

The thrombin-dependent enrichment of alkenylacyl ethanolamine phosphoglyceride in [14C]eicosapentaenoic acid ([14C]EPA) was demonstrated and compared with [3H]arachidonic acid ([3H]AA) following the simultaneous prelabelling of individual human platelet phospholipids with these two fatty acids. The alkenylacyl, diacyl, and alkylacyl classes of ethanolamine phosphoglycerides (PE) were separated by thin-layer chromatography as their acetylated derivatives after hydrolysis of the parent phospholipid with phospholipase C. The ratios of [3H]/[14C] for the increased radioactivity appearing in alkenylacyl PE following 60 and 120 s of thrombin stimulation were the same as the corresponding ratio (2.0) found in the choline phosphoglycerides (PC) from control (unstimulated) platelets. These results suggest no significant selectivity between EPA and AA in the thrombin-stimulated transfer of these fatty acids from diacyl PC to alkenylacyl PE. The present findings may possibly bear some relevance to the altered platelet reactivity and (or) decreased thromboxane A2 formation observed in human subjects following the ingestion of marine lipid containing EPA.


1991 ◽  
Vol 275 (2) ◽  
pp. 355-361 ◽  
Author(s):  
S Nakashima ◽  
A Suganuma ◽  
A Matsui ◽  
Y Nozawa

The 1,2-diacylglycerol (DAG) mass content was measured in thrombin-stimulated human platelets. Thrombin stimulates a biphasic accumulation of DAG, with an early phase reaching a peak at 10 s and a later phase reaching a peak at 2-3 min. The time course of first-phase DAG production corresponded well to that of Ins(1,4,5)P3 formation, which was rapid and transient. The second phase of DAG accumulation occurred after the level of Ins(1,4,5)P3 returned to nearly basal. Thrombin stimulated the decrease in PtdIns and phosphatidylcholine contents. The source of second-phase DAG was examined in platelets prelabelled with three radioactive fatty acids, i.e. arachidonic, palmitic and myristic. Thrombin stimulated the increase in radioactivity of DAG with decline of PtdIns in platelets labelled with [3H]arachidonic acid or [3H]palmitic acid, in which PtdIns was considerably labelled. In contrast, significant accumulation of [3H]DAG was not observed in [3H]myristic acid-labelled platelets, in which PtdIns was poorly labelled. In platelets prelabelled with [3H]inositol, an increase in InsP in response to thrombin was seen for more than 5 min. In contrast, upon stimulation, significant increases in [3H]phosphocholine and [3H]choline were not observed in [methyl-3H]choline-labelled platelets. Thrombin induced a small production of phosphatidylethanol, when ethanol was present during stimulation. However, the formation of DAG and phosphatidic acid was not significantly affected by ethanol. These results suggest that thrombin stimulates a biphasic accumulation of DAG, initially from PtdInsP2 and later from PtdIns in human platelets.


1984 ◽  
Vol 52 (03) ◽  
pp. 232-235 ◽  
Author(s):  
Juana Vallés ◽  
Justo Aznar ◽  
M Teresa Santos

SummarySome correlations between plasma and platelet fatty acids (FA) were evaluated “ex vivo” in 94 normal subjects.The highest relationships between total FA from plasma and platelets were found for 18:1 (r = 0.74) and 18:2 (r = 0.67). Low correlations were obtained for free fatty acids (FFA). The most significant correlations between fatty acids esterifying plasma and platelet phospholipids were found for the 18:1 (r = 0.66); 18:2 (r = 0.74) and 20:5 (r = 0.66).Our results suggest that the platelet phospholipid FA could be more easily modified by plasma variation in the FA composition of phospholipids than by variations in the plasma FA composition of the FFA fraction. In addition, the incorporation of FA from plasma into the platelet phospholipids “in vivo” may take place through an acylation-deacylation process and also by the incorporation of whole plasma phospholipid molecules into the platelets, probably through an exchange of plasma lipoproteins and platelets. Finally, arachidonic acid seems to have a different and selective way of incorporation into platelet phospholipids.


1979 ◽  
Author(s):  
M. Zuzel ◽  
A. Spencer

In the study of the effects on platelets of thromboxanes and prostaglandins (PG) large amounts of precursor fatty acids have frequently been added to platelet suspensions. In the case of DHLA, this results in a general inhibition of platelet reactions. We have employed kinetic analysis of the inhibition of ADP-induced primary platelet aggregation to estimate the potency, specificity and mode of action of DHLA on human platelets in citrated PRP. Platelet PG production was estimated from formation of malondialdehyde (MDA) and aspirin (ASA) was used to inhibit production-Inhibition of aggregation and MEA formation were dose-dependent and both were observed at DHLA concentrations of 0.1 mM and above. Inhibition of aggregation was of mixed type, consisting of an ASA-sensitive competitive component (K1 ≈ 0.2mM) and an ASA-insensitve component which was non-competitive and dominated inhibition at higher concentrations of DHLA. The KI (DHLA) of the non-competitive component varied from 0.4 to 1.5 mM with different batches of PRP. Other polyunsaturated fatty acids which are not PG precursors, did not cause competitive inhibition but were as potent as DHLA in the non-competitive inhibition of aggregation. The results show that a large part of the inhibition of platelet aggregation by DHLA in vitro is not due to its transformation into an inhibitor of platelet function in the PG production pathway.


Blood ◽  
1971 ◽  
Vol 38 (1) ◽  
pp. 27-38 ◽  
Author(s):  
MINORU OKUMA ◽  
MANFRED STEINER ◽  
MARIO BALDINI

Abstract Lipid content and capacity to incorporate in vitro palmitate-1-14C and linoleate-1-14C into lipids was investigated in fresh and stored (4°C) human platelets. Cholesterol and phospholipids decreased 30% during storage for 6 days. Molar ratio of cholesterol to phospholipids and percentage distribution of individual phospholipids were similar in fresh and stored platelets. Palmitate bound to albumin was rapidly transferred by an energy-independent mechanism into a free fatty acid fraction of platelets. From there it was incorporated into glycerides and phospholipids, a process requiring energy. More palmitate than linoleate was incorporated into fatty acids and glycerides of fresh and stored platelets but linoleate exceeded palmitate in its incorporation into phosphatidylethanolamine. Storage of platelets produced the following changes: (1) Incorporation of palmitate into total lipids was significantly reduced but not that of linoleate. (2) Both palmitate and linoleate showed increased incorporation into phosphatidylethanolamine. (3) Incorporation of linoleate into free fatty acids and triglycerides and of palmitate into phosphatidylcholine was reduced.


Sign in / Sign up

Export Citation Format

Share Document